Adenoma/etiology/genetics; Humans; Intracellular Signaling Peptides and Proteins/genetics; Models, Biological; Multiple Endocrine Neoplasia Type 1/complications/genetics; Mutation/physiology; Pituitary Neoplasms/etiology/genetics
Abstract :
[en] BACKGROUND: Pituitary adenomas occur in a familial setting in about 5% of all cases and over half of these are due to multiple endocrine neoplasia type 1 (MEN1) and Carney complex (CNC). Since the late 1990s, we have described non-MEN1/CNC familial pituitary tumors that include all tumor phenotypes and have named this condition 'familial isolated pituitary adenoma' (FIPA). Clinical features of FIPA differ from those of sporadic pituitary adenomas in that patients with FIPA are often younger and have larger tumors at diagnosis. About 15% of FIPA patients have mutations in the aryl hydrocarbon receptor interacting protein gene (AIP), which indicates that FIPA may have a diverse genetic pathophysiology. We review the clinical features of FIPA, the tumor pathologies found in this setting and the genetic/molecular data that have been recently reported. CONCLUSIONS: Clinically relevant pituitary adenomas are more common than previously thought and occur in a familial setting in about 5% of cases overall. Therefore, specific questioning regarding family history of pituitary disease should be part of the workup of all patients with pituitary adenomas, not just those with acromegaly. FIPA is a useful clinical framework to study the features of pituitary adenomas that occur in a familial setting since it encompasses all tumor phenotypes and heterogeneous/homogeneous expression among affected family members.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Daly, Adrian ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Tichomirowa, M. A.
Beckers, Albert ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Language :
English
Title :
Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
Wermer, P., Genetic aspects of adenomatosis of endocrine glands (1954) Am J Med, 16, pp. 363-371
Agarwal, S.K., Lee Burns, A., Sukhodolets, K.E., Kennedy, P.A., Obungu, V.H., Hickman, A.B., Mullendore, M.E., Marx, S.J., Molecular pathology of the MEN1 gene (2004) Ann N Y Acad Sci, 1014, pp. 189-198
Larsson, C., Skogseid, B., Oberg, K., Nakamura, Y., Nordenskjold, M., Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma (1988) Nature, 332, pp. 85-87
Chandrasekharappa, S.C., Guru, S.C., Manickam, P., Olufemi, S.E., Collins, F.S., Emmert-Buck, M.R., Debelenko, L.V., Marx, S.J., Positional cloning of the gene for multiple endocrine neoplasia-type 1 (1997) Science, 276, pp. 404-407
Lemos, M.C., Thakker, R.V., Multiple endocrine neoplasia type 1 (MEN1): Analysis of 1336 mutations reported in the first decade following identification of the gene (2008) Hum Mutat, 29, pp. 22-32
Agarwal, S.K., Impey, S., McWeeney, S., Scacheri, P.C., Collins, F.S., Goodman, R.H., Spiegel, A.M., Marx, S.J., Distribution of menin-occupied regions in chromatin specifies a broad role of menin in transcriptional regulation (2007) Neoplasia, 9, pp. 101-107
Vergès, B., Boureille, F., Goudet, P., Murat, A., Beckers, A., Sassolas, G., Cougard, P., Calender, A., Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study (2002) J Clin Endocrinol Metab, 87, pp. 457-465
Beckers, A., Betea, D., Valdes Socin, H., Stevenaert, A., The treatment of sporadic versus MEN1-related pituitary adenomas (2003) J Intern Med, 253, pp. 599-605
Boikos, S.A., Stratakis, C.A., Carney complex: The first 20 years (2007) Curr Opin Oncol, 19, pp. 24-29
Stratakis, C.A., Kirschner, L.S., Carney, J.A., Clinical and molecular features of the Carney complex: Diagnostic criteria and recommendations for patient evaluation (2001) J Clin Endocrinol Metab, 86, pp. 4041-4046
Casey, M., Mah, C., Merliss, A.D., Kirschner, L.S., Taymans, S.E., Denio, A.E., Korf, B., Basson, C.T., Identification of a novel genetic locus for familial cardiac myxomas and Carney complex (1998) Circulation, 98, pp. 2560-2566
Fritz, A., Walch, A., Piotrowska, K., Rosemann, M., Schäffer, E., Weber, K., Timper, A., Atkinson, M.J., Recessive transmission of a multiple endocrine neoplasia syndrome in the rat (2002) Cancer Res, 62, pp. 3048-3051
Pellegata, N.S., Quintanilla-Martinez, L., Siggelkow, H., Samson, E., Bink, K., Höfler, H., Fend, F., Atkinson, M.J., Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans (2006) Proc Natl Acad Sci USA, 103, pp. 15558-15563
Georgitsi, M., Raitila, A., Karhu, A., van der Luijt, R.B., Aalfs, C.M., Sane, T., Vierimaa, O., Aaltonen, L.A., Germline CDKN1B/ p27Kip1 mutation in multiple endocrine neoplasia (2007) J Clin Endocrinol Metab, 92, pp. 3321-3325
Ozawa, A., Agarwal, S.K., Mateo, C.M., Burns, A.L., Rice, T.S., Kennedy, P.A., Quigley, C.M., Marx, S.J., The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations (2007) J Clin Endocrinol Metab, 92, pp. 1948-1951
Sternberg, M., (1899) Acromegaly, (169). , transl. FRB Atkinson, The New Sydenham Society, London
Teh BT, Kytölä S, Farnebo F, Bergman L, Wong FK, Weber G, Hayward N, Larsson C, Skogseid B, Beckers A, Phelan C, Edwards M, Epstein M, Alford F, Hurley D, Grimmond S, Silins G, Walters M, Stewart C, Cardinal J, Khodaei S, Parente F, Tranebjaerg L, Jorde R, Menon J, Khir A, Tan TT, Chan SP, Zaini A, Khalid BAK, Sandelin K, Thompson N, Brandi ML, Warth M, Stock J, Leisti J, Cameron D, Shepherd JJ, Öberg K, Nordenskjöld M, Salmela P: Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 1998
83:2621-2626
Luccio-Camelo, D.C., Une, K.N., Ferreira, R.E., Khoo, S.K., Nickolov, R., Bronstein, M.D., Vaisman, M., Gadelha, M.R., A meiotic recombination in a new isolated familial somatotropinoma kindred (2004) Eur J Endocrinol, 150, pp. 643-648
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Aaltonen, L.A., Pituitary adenoma predisposition caused by germline mutations in the AIP gene (2006) Science, 312, pp. 1228-1230
Scheithauer, B.W., Laws Jr, E.R., Kovacs, K., Horvath, E., Randall, R.V., Carney, J.A., Pituitary adenomas of the multiple endocrine neoplasia type I syndrome (1987) Semin Diagn Pathol, 4, pp. 205-211
Beckers, A., Daly, A.F., The clinical, pathological, and genetic features of familial isolated pituitary adenomas (2007) Eur J Endocrinol, 157, pp. 371-382
Villa, C., Magri, F., Morbini, P., Falchetti, A., Scagnelli, P., Lovati, E., Locatelli, D., Solcia, E., Silent familial isolated pituitary adenomas: Histopathological and clinical case report (2008) Endocr Pathol, , Epub ahead of print
Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira A Jr, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB, Korbonits M: The role of the AIP gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 2008
93:2390-2401
Daly, A.F., Jaffrain-Rea, M.L., Ciccarelli, A., Valdes-Socin, H., Rohmer, V., Tamburrano, G., Borson-Chazot, C., Beckers, A., Clinical characterization of familial isolated pituitary adenomas (2006) J Clin Endocrinol Metab, 91, pp. 3316-3323
Ciccarelli, A., Daly, A.F., Beckers, A., The epidemiology of prolactinomas (2005) Pituitary, 8, pp. 3-6
Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabaté MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wémeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montañana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A: Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 2007
92:1891-1896
Iwata, T., Yamada, S., Mizusawa, N., Golam, H.M., Sano, T., Yoshimoto, K., The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas (2007) Clin Endocrinol (Oxf), 66, pp. 499-502
Toledo, R.A., Lourenco Jr, D.M., Liberman, B., Cunha-Neto, M.B., Cavalcanti, M.G., Moyses, C.B., Toledo, S.P., Dahia, P.L., Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma (2007) J Clin Endocrinol Metab, 92, pp. 1934-1937
Yu, R., Bonert, V., Saporta, I., Raffel, L.J., Melmed, S., AIP variants in sporadic pituitary adenomas (2006) J Clin Endocrinol Metab, 91, pp. 5126-5129
Barlier, A., Vanbellinghen, J.F., Daly, A.F., Silvy, M., Jaffrain-Rea, M.L., Trouillas, J., Tamagno, G., Beckers, A., Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas (2007) J Clin Endocrinol Metab, 92, pp. 1952-1955
Georgitsi, M., Raitila, A., Karhu, A., Tuppurainen, K., Makinen, M.J., Vierimaa, O., Paschke, R., Aaltonen, L.A., Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations (2007) Proc Natl Acad Sci USA, 104, pp. 4101-4105
Georgitsi, M., Karhu, A., Winqvist, R., Visakorpi, T., Waltering, K., Vahteristo, P., Launonen, V., Aaltonen, L.A., Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers (2007) Br J Cancer, 96, pp. 352-356
Petrulis, J.R., Perdew, G.H., The role of chaperone proteins in the aryl hydrocarbon receptor core complex (2002) Chem Biol Interact, 141, pp. 25-40
Bolger, G.B., Peden, A.H., Steele, M.R., MacKenzie, C., McEwan, D.G., Wallace, D.A., Huston, E., Houslay, M.D., Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2 (2003) J Biol Chem, 278, pp. 33351-33363
de Oliveira, S.K., Hoffmeister, M., Gambaryan, S., Muller-Esterl, W., Guimaraes, J.A., Smolenski, A.P., Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor (2007) J Biol Chem, 282, pp. 13656-13663
Lin, B.C., Sullivan, R., Lee, Y., Moran, S., Glover, E., Bradfield, C.A., Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality (2007) J Biol Chem, 282, pp. 35924-35932
Naves, L.A., Daly, A.F., Vanbellinghen, J.F., Casulari, L.A., Spilioti, C., Magalhães, A.V., Azevedo, M.F., Beckers, A., Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene (2007) Eur J Endocrinol, 157, pp. 383-391
